Augmentation of the effects of vasoactive intestinal peptide aerosol on pulmonary hypertension via co-application of a neutral endopeptidase 24.11 inhibitor

Author(s):  
Hanno Leuchte ◽  
Christoph Prechtl ◽  
Jens Callegari ◽  
Tobias Meis ◽  
Shani Haziraj ◽  
...  
2015 ◽  
Vol 308 (6) ◽  
pp. L563-L568 ◽  
Author(s):  
Hanno H. Leuchte ◽  
Christoph Prechtl ◽  
Jens Callegari ◽  
Tobias Meis ◽  
Shani Haziraj ◽  
...  

A deficiency of the pulmonary vasodilative vasoactive intestinal peptide (VIP) has been suggested to be involved in the pathophysiology of pulmonary hypertension (PH). Supplementation of VIP as an aerosol is hampered by the fact that it is rapidly inactivated by neutral endopeptidases (NEP) located on the lung surface. Coapplication of thiorphan, an NEP 24.11 inhibitor, could augment the biological effects of inhaled VIP alone. A stable pulmonary vasoconstriction with a threefold increase of pulmonary artery pressure was established by application the thromboxane mimetic U46619 in the isolated rabbit lung model. VIP and thiorphan were either applied intravascularly or as an aerosol. VIP caused a significant pulmonary vasodilation either during intravascular application or inhalation. These effects were of short duration. Thiorphan application had no effects on pulmonary vasoconstriction per se but significantly augmented the effects of VIP aerosol. Thiorphan, not only augmented the maximum hemodynamic effects of VIP aerosol, but also led to a significant prolongation of these effects. VIP causes pulmonary vasodilation in a model of acute experimental PH. The hemodynamic effects of VIP aerosol can be significantly augmented via coapplication of an NEP inhibitor.


1990 ◽  
Vol 265 (24) ◽  
pp. 14150-14155
Author(s):  
J. Vijayaraghavan ◽  
A.G. Scicli ◽  
O.A. Carretero ◽  
C. Slaughter ◽  
C. Moomaw ◽  
...  

1995 ◽  
Vol 5 (2) ◽  
pp. 151-154 ◽  
Author(s):  
Stéphane De Lombaer ◽  
Louis Blanchard ◽  
Carol Berry ◽  
Rajendra D. Ghai ◽  
Angelo J. Trapani

Blood ◽  
2003 ◽  
Vol 102 (8) ◽  
pp. 3028-3034 ◽  
Author(s):  
Soohee Lee ◽  
Asim K. Debnath ◽  
Colvin M. Redman

Abstract In addition to its importance in transfusion, Kell protein is a member of the M13 family of zinc endopeptidases and functions as an endothelin-3–converting enzyme. To obtain information on the structure of Kell protein we built a model based on the crystal structure of the ectodomain of neutral endopeptidase 24.11 (NEP). Similar to NEP, the Kell protein has 2 globular domains consisting mostly of α-helical segments. The domain situated closest to the membrane contains both the N- and C-terminal sequences and the enzyme-active site. The outer domain contains all of the amino acids whose substitutions lead to different Kell blood group phenotypes. In the model, the zinc peptidase inhibitor, phosphoramidon, was docked in the active site. Site-directed mutagenesis of amino acids in the active site was performed and the enzymatic activities of expressed mutant Kell proteins analyzed and compared with NEP. Our studies indicate that Kell and NEP use the same homologous amino acids in the coordination of zinc and in peptide hydrolysis. However, Kell uses different amino acids than NEP in substrate binding and appears to have more flexibility in the composition of amino acids allowed in the active site.


2006 ◽  
Vol 17 (1) ◽  
pp. 16-38 ◽  
Author(s):  
David S. Cohen ◽  
Cynthia A. Fink ◽  
Angelo J. Trapani ◽  
Randy L. Webb ◽  
Patricia A. Zane ◽  
...  

Biochemistry ◽  
1987 ◽  
Vol 26 (14) ◽  
pp. 4237-4242 ◽  
Author(s):  
Robert C. Bateman ◽  
Louis B. Hersh

Sign in / Sign up

Export Citation Format

Share Document